192 related articles for article (PubMed ID: 29325236)
1. Treatment With a Ghrelin Agonist in Outpatient Women With Anorexia Nervosa: A Randomized Clinical Trial.
Fazeli PK; Lawson EA; Faje AT; Eddy KT; Lee H; Fiedorek FT; Breggia A; Gaal IM; DeSanti R; Klibanski A
J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29325236
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
Camilleri M; McCallum RW; Tack J; Spence SC; Gottesdiener K; Fiedorek FT
Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
[TBL] [Abstract][Full Text] [Related]
3. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
[TBL] [Abstract][Full Text] [Related]
4. Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial.
Acosta A; Camilleri M; Kolar G; Iturrino J; Szarka LA; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR; Spence SC; Gottesdiener K; Bouras EP; Vazquez-Roque MI
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2312-9.e1. PubMed ID: 26001337
[TBL] [Abstract][Full Text] [Related]
5. Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers.
Nelson AD; Camilleri M; Acosta A; Busciglio I; Linker Nord S; Boldingh A; Rhoten D; Ryks M; Burton D
Neurogastroenterol Motil; 2016 Nov; 28(11):1705-1713. PubMed ID: 27283792
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study.
Hotta M; Ohwada R; Akamizu T; Shibasaki T; Takano K; Kangawa K
Endocr J; 2009; 56(9):1119-28. PubMed ID: 19755753
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of cisapride in anorexia nervosa.
Szmukler GI; Young GP; Miller G; Lichtenstein M; Binns DS
Int J Eat Disord; 1995 May; 17(4):347-57. PubMed ID: 7620474
[TBL] [Abstract][Full Text] [Related]
8. Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist.
Camilleri M; Acosta A
Neurogastroenterol Motil; 2015 Mar; 27(3):324-32. PubMed ID: 25545036
[TBL] [Abstract][Full Text] [Related]
9. Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data.
Camilleri M; Lembo A; McCallum R; Tourkodimitris S; Kemps L; Miller MB; Bertelsen K; Iacob A
Aliment Pharmacol Ther; 2020 Jun; 51(11):1139-1148. PubMed ID: 32301137
[TBL] [Abstract][Full Text] [Related]
10. Prospective, randomized, double-blind, placebo-controlled phase IIa clinical trial on the effects of an estrogen-progestin combination as add-on to inpatient psychotherapy in adult female patients suffering from anorexia nervosa.
Paslakis G; Maas S; Gebhardt B; Mayr A; Rauh M; Erim Y
BMC Psychiatry; 2018 Apr; 18(1):93. PubMed ID: 29631553
[TBL] [Abstract][Full Text] [Related]
11. D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.
Levinson CA; Rodebaugh TL; Fewell L; Kass AE; Riley EN; Stark L; McCallum K; Lenze EJ
J Clin Psychiatry; 2015 Jun; 76(6):e787-93. PubMed ID: 26132687
[TBL] [Abstract][Full Text] [Related]
12. [Neuropeptide Y, ghrelin and leptin plasma levels in anorexia nervosa patients and their changes during six-week refeeding].
Beranová L; Sedlácková D; Kopecková J; Hainer V; Papezová H; Kvasnicková H; Nedvídková J
Vnitr Lek; 2009 Oct; 55(10):925-8. PubMed ID: 19947235
[TBL] [Abstract][Full Text] [Related]
13. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
[TBL] [Abstract][Full Text] [Related]
14. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa.
Otto B; Cuntz U; Fruehauf E; Wawarta R; Folwaczny C; Riepl RL; Heiman ML; Lehnert P; Fichter M; Tschöp M
Eur J Endocrinol; 2001 Nov; 145(5):669-73. PubMed ID: 11720888
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial.
Walsh BT; Kaplan AS; Attia E; Olmsted M; Parides M; Carter JC; Pike KM; Devlin MJ; Woodside B; Roberto CA; Rockert W
JAMA; 2006 Jun; 295(22):2605-12. PubMed ID: 16772623
[TBL] [Abstract][Full Text] [Related]
16. Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride.
Stacher G; Abatzi-Wenzel TA; Wiesnagrotzki S; Bergmann H; Schneider C; Gaupmann G
Br J Psychiatry; 1993 Mar; 162():398-402. PubMed ID: 8453437
[TBL] [Abstract][Full Text] [Related]
17. Erythromycin effects on gastric emptying, antral motility and plasma motilin and pancreatic polypeptide concentrations in anorexia nervosa.
Stacher G; Peeters TL; Bergmann H; Wiesnagrotzki S; Schneider C; Granser-Vacariu GV; Gaupmann G; Kugi A
Gut; 1993 Feb; 34(2):166-72. PubMed ID: 8432466
[TBL] [Abstract][Full Text] [Related]
18. Gastric emptying and symptoms of bulimia nervosa: effect of a prokinetic agent.
Devlin MJ; Kissileff HR; Zimmerli EJ; Samuels F; Chen BE; Brown AJ; Geliebter A; Walsh BT
Physiol Behav; 2012 May; 106(2):238-42. PubMed ID: 22361261
[TBL] [Abstract][Full Text] [Related]
19. Definition of a gastric emptying abnormality in patients with anorexia nervosa.
McCallum RW; Grill BB; Lange R; Planky M; Glass EE; Greenfeld DG
Dig Dis Sci; 1985 Aug; 30(8):713-22. PubMed ID: 4017831
[TBL] [Abstract][Full Text] [Related]
20. Relamorelin in Gastroparesis and Diabetic Gastroparesis: A Meta-Analysis on Its Efficacy and Safety.
Patel A; Arora GS; Roknsharifi M; Javed H; Kaur P
Cureus; 2023 Nov; 15(11):e48303. PubMed ID: 38058346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
